Journal of International Psychiatry

[Abstract] Objective: To study and analyze the depression and anxiety status of patients with chronic kidney disease at different stages. Method: 100 patients with chronic kidney disease admitted to our hospital from 2021 to January 2023 were selected as the research subjects. Based on the glomerular filtration rate, they were divided into two groups: the CKD5 stage group and the CKD1-4 stage group. Their depression and anxiety status were evaluated using the Self Rating Depression Scale (SDS) and the Self Rating Anxiety Scale (SAS). Result: Among the 100 patients in this group, 63 were in CDK1-4 phase, accounting for 63.0%, and 37 were in CKD5 phase, accounting for 37%; Compared with the normal population in China, CKD patients have higher SDS and SAS scores, with significant differences (P<0.05); The SDS score of the CKD5 stage group was significantly higher than that of the CKD1-4 stage group (P<0.05); However, there was no statistically significant difference in SAS scores between the two groups (P>0.05); At the same time, the presence or absence of depression and anxiety symptoms were used as dependent variables to construct a logistic regression model. The results showed that the presence of depression and anxiety symptoms in CKD patients was related to age and disease stage (P<0.05). Conclusion: Patients with chronic kidney disease often have different levels of depression and anxiety, and as age increases and kidney function decreases, the degree of depression and anxiety worsens. Therefore, it is necessary to strengthen psychological intervention to reduce negative emotions, which can help improve patient prognosis.

Keywords: Chronic kidney disease; Depression; anxious